查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球临床试验支持服务市场预测（2022-2030）
市场调查报告书
商品编码
1121483

全球临床试验支持服务市场预测（2022-2030）

Global Clinical Trials Support Services Market Forecast 2022-2030
出版日期: | 出版商: Inkwood Research | 英文 230 Pages | 商品交期: 2-3个工作天内

价格

从 2022 年到 2030 年（评估期），全球临床试验支持服务市场预计将以 7.65% 的复合年增长率增长。市场增长因素包括慢性病和病毒爆发的流行率上升以及临床试验支持服务的各种好处。

按地区划分，由于该地区有几家行业主要参与者和先进的临床研究，预计到 2030 年北美市场将占据约 38.27% 的市场份额。

本报告审查了全球临床试验支持服务市场，并提供了市场规模和预测、市场动态、按细分市场/地区划分的市场分析、竞争格局和主要参与者概况等信息。

内容

第一章研究范围与研究方法

  • 调查目的
  • 调查范围
  • 调查方法
  • 先决条件和限制

第 2 章执行摘要

  • 市场规模和估计
  • 市场概览

第三章市场动态

  • 主要驱动力
    • 慢性病和病毒的发病率不断上升
    • 临床试验支持服务的好处
  • 主要製约因素
    • 开源/免费软件的可用性
    • 严格的规定

第四章关键分析

  • COVID-19 对临床试验支持服务的影响
  • 主要市场趋势
  • 波特五力分析
  • 机会矩阵
  • 供应商情况
  • 价值链分析
  • 主要购买标准
  • 监管框架

第 5 章市场分阶段

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第 6 章赞助商市场

  • 製药和生物製药公司
  • 医疗器械公司
  • 其他

第 7 章按服务划分的市场

  • 临床试验设施的管理
  • 管理人员
  • 患者招募管理
    • 患者招募和挂号服务
    • 留住病人
    • 其他
  • IRB
  • 数据管理
  • 其他服务

第八章区域分析

  • 北美
    • 市场规模和估计
    • 主要增长因素
    • 主要问题
    • 主要公司
    • 国家/地区分析
  • 欧洲
    • 市场规模和估计
    • 主要增长因素
    • 主要问题
    • 主要公司
    • 国家/地区分析
  • 亚太地区
    • 市场规模和估计
    • 主要增长因素
    • 主要问题
    • 主要公司
    • 国家/地区分析
  • 世界其他地区
    • 市场规模和估计
    • 主要增长因素
    • 主要问题
    • 主要公司
    • 国家/地区分析

第 9 章竞争格局

  • 重大战略发展
    • 併购
    • 产品发布和开发
    • 合作伙伴关係和合同
    • 业务扩展和销售
  • 公司简介
    • ADVANCED CLINICAL
    • ALCURA
    • CHARLES RIVER LABORATORIES INC
    • CLINIPACE
    • CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
    • ICON PLC
    • IQVIA
    • KCR
    • LABCORP DRUG DEVELOPMENT
    • MEDPACE
    • PAREXEL
    • PSI CRO
    • SYNEOS HEALTH
    • WORLDWIDE CLINICAL TRIALS
    • WUXI APPTEC
Product Code: 47763

KEY FINDINGS

The global clinical trials support services market is estimated to boost with a 7.65% CAGR during the assessment period, 2022-2030. The market growth is driven by the rising prevalence of chronic disease & virus outbreaks and various benefits of clinical trial support services.

MARKET INSIGHTS

Clinical trials are controlled studies on humans to ensure the efficacy of drugs, food, and other product. These clinical trials are designed to satisfy the requirements of an agency related to product approvals and other human studies used in developing a product. Experiments and tests are performed on people and animals, and later the researchers or the investigators examine the outcomes

Further, support services make the clinical trial process easier. There are various key drivers for the growth of the studied market: the rise in the number of diseases and overcoming the challenges in clinical trials. The rising health problems and diseases have increased the clinical trials of new vaccines for new viruses and new and efficient drugs for the existing problems.

REGIONAL INSIGHTS

The global clinical trials support services market growth evaluation includes a thorough analysis of Europe, North America, Asia-Pacific, and Rest of World. North America is expected to capture around 38.27% market share by 2030 due to the presence of numerous leading industry players and advanced clinical studies in the region.

COMPETITIVE INSIGHTS

The competition is very high among the companies since the global clinical trials support services market is consolidated. Also, there are entry barriers for new entrants because of the presence of influential market leaders.

Some of the key market players include: ICON PLC, IQVIA, Parexel, PSI CRO, KCR, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. RISING PREVALENCE OF CHRONIC DISEASE & VIRUS OUTBREAKS
    • 3.1.2. BENEFITS OF CLINICAL TRIAL SUPPORT SERVICES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. AVAILABILITY OF OPEN-SOURCE/FREEWARE SOFTWARE
    • 3.2.2. STRINGENT REGULATIONS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON CLINICAL TRIALS SUPPORT SERVICES MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. VALUE CHAIN ANALYSIS
  • 4.7. KEY BUYING CRITERIA
    • 4.7.1. PERFORMANCE
    • 4.7.2. EASE OF USE
    • 4.7.3. SECURITY
    • 4.7.4. COST-EFFECTIVENESS
  • 4.8. REGULATORY FRAMEWORK

5. MARKET BY PHASE

  • 5.1. PHASE I
  • 5.2. PHASE II
  • 5.3. PHASE III
  • 5.4. PHASE IV

6. MARKET BY SPONSOR

  • 6.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
  • 6.2. MEDICAL DEVICE COMPANIES
  • 6.3. OTHER SPONSORS

7. MARKET BY SERVICE

  • 7.1. CLINICAL TRIAL SITE MANAGEMENT
  • 7.2. ADMINISTRATIVE STAFF
  • 7.3. PATIENT RECRUITMENT MANAGEMENT
    • 7.3.1. PATIENT RECRUITMENT & REGISTRY SERVICES
    • 7.3.2. PATIENT RETENTION
    • 7.3.3. OTHER PATIENT RECRUITMENT MANAGEMENT
  • 7.4. IRB
  • 7.5. DATA MANAGEMENT
  • 7.6. OTHER SERVICES

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. KEY GROWTH ENABLERS
    • 8.1.3. KEY CHALLENGES
    • 8.1.4. KEY PLAYERS
    • 8.1.5. COUNTRY ANALYSIS
      • 8.1.5.1. UNITED STATES
      • 8.1.5.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. MARKET SIZE & ESTIMATES
    • 8.2.2. KEY GROWTH ENABLERS
    • 8.2.3. KEY CHALLENGES
    • 8.2.4. KEY PLAYERS
    • 8.2.5. COUNTRY ANALYSIS
      • 8.2.5.1. UNITED KINGDOM
      • 8.2.5.2. GERMANY
      • 8.2.5.3. FRANCE
      • 8.2.5.4. SPAIN
      • 8.2.5.5. ITALY
      • 8.2.5.6. SWEDEN
      • 8.2.5.7. DENMARK
      • 8.2.5.8. HUNGARY
      • 8.2.5.9. REST OF EUROPE
  • 8.3. ASIA-PACIFIC
    • 8.3.1. MARKET SIZE & ESTIMATES
    • 8.3.2. KEY GROWTH ENABLERS
    • 8.3.3. KEY CHALLENGES
    • 8.3.4. KEY PLAYERS
    • 8.3.5. COUNTRY ANALYSIS
      • 8.3.5.1. CHINA
      • 8.3.5.2. JAPAN
      • 8.3.5.3. INDIA
      • 8.3.5.4. SOUTH KOREA
      • 8.3.5.5. TAIWAN
      • 8.3.5.6. SINGAPORE
      • 8.3.5.7. THAILAND
      • 8.3.5.8. AUSTRALIA & NEW ZEALAND
      • 8.3.5.9. REST OF ASIA-PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. MARKET SIZE & ESTIMATES
    • 8.4.2. KEY GROWTH ENABLERS
    • 8.4.3. KEY CHALLENGES
    • 8.4.4. KEY PLAYERS
    • 8.4.5. COUNTRY ANALYSIS
      • 8.4.5.1. LATIN AMERICA
      • 8.4.5.2. MIDDLE EAST & AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGERS & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 9.1.3. PARTNERSHIPS & AGREEMENTS
    • 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
  • 9.2. COMPANY PROFILES
    • 9.2.1. ADVANCED CLINICAL
    • 9.2.2. ALCURA
    • 9.2.3. CHARLES RIVER LABORATORIES INC
    • 9.2.4. CLINIPACE
    • 9.2.5. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
    • 9.2.6. ICON PLC
    • 9.2.7. IQVIA
    • 9.2.8. KCR
    • 9.2.9. LABCORP DRUG DEVELOPMENT
    • 9.2.10. MEDPACE
    • 9.2.11. PAREXEL
    • 9.2.12. PSI CRO
    • 9.2.13. SYNEOS HEALTH
    • 9.2.14. WORLDWIDE CLINICAL TRIALS
    • 9.2.15. WUXI APPTEC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CLINICAL TRIALS SUPPORT SERVICES
  • TABLE 2: LIST OF PANDEMIC OUTBREAKS
  • TABLE 3: LIST OF OPEN-SOURCE SOFTWARE
  • TABLE 4: LIST OF PARTNERSHIPS
  • TABLE 5: LAUNCH OF MEDICAL DRUGS
  • TABLE 6: PROMISING ACQUISITIONS IN THE INDUSTRY
  • TABLE 7: REGULATORY FRAMEWORK
  • TABLE 8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 10: GLOBAL PHASE I MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 11: GLOBAL PHASE I MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 12: GLOBAL PHASE II MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 13: GLOBAL PHASE II MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 14: GLOBAL PHASE III MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 15: GLOBAL PHASE III MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 16: GLOBAL PHASE IV MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 17: GLOBAL PHASE IV MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 20: GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 21: GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 22: GLOBAL MEDICAL DEVICE COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 23: GLOBAL MEDICAL DEVICE COMPANIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 24: GLOBAL OTHER SPONSORS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 25: GLOBAL OTHER SPONSORS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 26: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 27: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 28: GLOBAL CLINICAL TRIAL SITE MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 29: GLOBAL CLINICAL TRIAL SITE MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 30: GLOBAL ADMINISTRATIVE STAFF MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 31: GLOBAL ADMINISTRATIVE STAFF MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 32: GLOBAL PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 33: GLOBAL PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 34: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 35: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 36: GLOBAL PATIENT RECRUITMENT & REGISTRY SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 37: GLOBAL PATIENT RECRUITMENT & REGISTRY SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 38: GLOBAL PATIENT RETENTION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 39: GLOBAL PATIENT RETENTION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 40: GLOBAL OTHER PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 41: GLOBAL OTHER PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 42: GLOBAL IRB MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 43: GLOBAL IRB MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 44: GLOBAL DATA MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 45: GLOBAL DATA MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 46: GLOBAL OTHER SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 47: GLOBAL OTHER SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 48: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 49: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 50: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 51: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 52: LEADING PLAYERS OPERATING IN NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET
  • TABLE 53: NUMBER AND TYPES OF REGISTERED STUDIES
  • TABLE 54: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 55: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 56: LEADING PLAYERS OPERATING IN EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET
  • TABLE 57: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 58: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 59: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET
  • TABLE 60: REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 61: REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 62: LEADING PLAYERS OPERATING IN REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET
  • TABLE 63: LIST OF MERGERS & ACQUISITIONS
  • TABLE 64: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 65: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 66: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: VALUE CHAIN ANALYSIS
  • FIGURE 6: KEY BUYING CRITERIA
  • FIGURE 7: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PHASE, IN 2021
  • FIGURE 8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2030 (IN $ MILLION)
  • FIGURE 9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2030 (IN $ MILLION)
  • FIGURE 10: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2030 (IN $ MILLION)
  • FIGURE 11: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2030 (IN $ MILLION)
  • FIGURE 12: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SPONSOR, IN 2021
  • FIGURE 13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
  • FIGURE 14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2030 (IN $ MILLION)
  • FIGURE 15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2030 (IN $ MILLION)
  • FIGURE 16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021
  • FIGURE 17: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE STAFF, 2022-2030 (IN $ MILLION)
  • FIGURE 19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 20: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PATIENT RECRUITMENT MANAGEMENT, IN 2021
  • FIGURE 21: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT & REGISTRY SERVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 22: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RETENTION, 2022-2030 (IN $ MILLION)
  • FIGURE 23: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 24: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY IRB, 2022-2030 (IN $ MILLION)
  • FIGURE 25: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 26: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 27: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 28: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 29: CANADA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 30: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 31: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 32: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 33: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 34: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 35: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 36: SWEDEN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 37: DENMARK CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 38: HUNGARY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 39: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 40: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 41: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 42: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 43: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 44: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 45: TAIWAN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 46: SINGAPORE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 47: THAILAND CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 48: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 49: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 50: REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 51: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 52: MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)